PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors

Author(s):
Beyrend, G. (0000-0001-9044-3486); Gracht, E. van der; Yilmaz, A.; Duikeren, S. van; Camps, M.; Hollt, T.; Vilanova, A.; Unen, V. van; Koning, F. (0000-0002-4007-5715); Miranda, N.F.C.C. de; Arens, R.; Ossendorp, F.
Published
2019
Publication type
Article / Letter to editor
Mass cytometryCombinatorial immunotherapyT cells
Date issued
2019-08-14
Language
English
Is part of
Journal for ImmunoTherapy of Cancer (2019), No. 1
hdl
1887/120606
doi
10.1186/s40425-019-0700-3